BJR -- Barak et al. 78 (933): 827 Figure 2

Click on image to view larger version.

Figure 2. The percentage of patients (y-axis) who lost 3 and $≥$ 6 at 12 months following treatment as distributed among the various treatment groups (x-axis). Overall, 18% of patients lost $≥$ 3 lines of VA and 10% lost $≥$ 6 lines. The VA remained within ±3 lines of the baseline value in 82% of patients.